|
|
Post by vark on Jul 23, 2014 9:43:46 GMT -5
|
|
mike
Moderator 
Posts: 334
|
Post by mike on Jul 23, 2014 18:52:49 GMT -5
Hm, the vitims were old people who had one foot in the grave already, which is probably why they got light sentences. Seems only vaguely related to the kind of studies done here, I have never heard of a study for a product like that, soing apparently intended to reconstruct spine bone?
|
|
|
|
Post by vark on Jul 26, 2014 13:07:34 GMT -5
|
|
|
|
Post by vark on Aug 1, 2014 12:15:46 GMT -5
www.the-american-interest.com/blog/2014/07/31/the-u-s-health-care-system-the-global-sugar-daddy/A new pill for hepatitis C is unmasking a huge global inequality in pharmaceutical costs—one that disproportionately burdens the United States. The FT has a must-read report on Solvadi, a drug developed by Gilead Sciences that costs $84,000 for a 12-week course of treatment for American patients, but sells for a song in other countries—as low as $11....my guess is this is partly due to the regulatory costs of FDA approval, and partly because the usa has the single biggest market of people who can afford to pay the high costs of drug development.
|
|
mike
Moderator
Posts: 334
|
Post by mike on Aug 1, 2014 13:45:11 GMT -5
I have heard information on this for a number of years now.
It's crazy, I can understand if drug prices are quite a bit lower in countries like Mexico, but we pay more than pretty much ANYONE,
go to Canada or any number of European countries that have a standard of living as good or better than the U.S., and they still are charged less for drugs than we are.
It's like we are singled out for the top level shafting.
|
|
|
|
Post by vark on Mar 3, 2015 15:37:22 GMT -5
|
|
